BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3796871)

  • 1. [A combination of pirenzepine with ranitidine in the treatment of refractory duodenal ulcer].
    Calabrò A; Salvadori G; Parenti S; Sani S; Ceccatelli P; Valentini P; Surrenti C
    Minerva Dietol Gastroenterol; 1986; 32(3):291-5. PubMed ID: 3796871
    [No Abstract]   [Full Text] [Related]  

  • 2. [A cimetidine-pirenzepine combination in the treatment of patients with duodenal ulcer resistant to therapy with cimetidine or ranitidine. Our experience in 22 cases].
    Capretti PG; Montalto C; Turi V; Gianni E; Marcolli G
    Minerva Dietol Gastroenterol; 1988; 34(1):31-7. PubMed ID: 3386862
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duodenal ulcer recurrences after treatment with pirenzepine and ranitidine.
    Dzieniszewski J; Knapik Z; Pokora J; Kosieradzki W; Jarosz O; Woźniak-Stolarska B; Radwan P
    Mater Med Pol; 1987; 19(3):196-9. PubMed ID: 3450981
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined ranitidine and pirenzepine in the treatment of duodenal ulcer: a multicentre double-blind study using endoscopy.
    Bianchi Porro G; Lazzaroni M; Mazzacca G; Piai G; Dal Monte PR; Colombo E; Ferrara A; Prada A; Battocchia A; Venturelli R
    J Int Med Res; 1990; 18(5):341-50. PubMed ID: 2257957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
    Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
    Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of single nocturnal dose of pirenzepine versus ranitidine in duodenal ulcer.
    Contractor QQ; Benson L; Contractor TQ; Schulz T
    Indian J Gastroenterol; 1988 Jul; 7(3):165-6. PubMed ID: 3397140
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
    Giacosa A; Cheli R; Molinari F; Parodi MC
    Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of H2 antagonists and interaction with anticholinergics.
    Savarino V; Mela GS; Celle G
    Am J Gastroenterol; 1989 Nov; 84(11):1463-4. PubMed ID: 2816882
    [No Abstract]   [Full Text] [Related]  

  • 10. The association of ranitidine and sucralfate in the short-term treatment of duodenal ulcers, as compared to other forms of treatment.
    Magnanelli M; Belvisi A; Toninelli A; Matergi M; Camarri E
    Int J Tissue React; 1984; 6(2):189-93. PubMed ID: 6329980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term therapy of Ménétrier disease using ranitidine and pirenzepine].
    Meyenberger C; Altorfer J; Münch R; Müller A; Ammann R
    Schweiz Med Wochenschr; 1991 Jun; 121(23):877-80. PubMed ID: 1857946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Josamycin combination with ranitidine in therapy of gastroduodenal ulcer: clinical efficiency].
    Maev IV; Vertkin AL; Vovk EI; Masharova AA; Bezborodnyĭ SD; Lebedeva EG
    Klin Med (Mosk); 2000; 78(3):46-50. PubMed ID: 10790966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of pirenzepine and cimetidine in the therapy of duodenal ulcer.
    Chiverton SG; Hunt RH
    Am J Gastroenterol; 1988 Aug; 83(8):891-2. PubMed ID: 3394692
    [No Abstract]   [Full Text] [Related]  

  • 14. A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in "non-responders".
    Dal Monte PR; D'Imperio M; Ferri M; Fratucello F; del Soldato P
    Hepatogastroenterology; 1985 Jun; 32(3):126-8. PubMed ID: 3839484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zantac (ranitidine) in treating duodenal ulcers].
    Vasil'ev IuV
    Eksp Klin Gastroenterol; 2002; (3):68-70, 121. PubMed ID: 12353395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
    Pöch G; Londong W
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etintidine versus ranitidine: a single evening dose in the treatment of duodenal ulcer].
    Dammann HG; Walter TA; Müller P; Simon B
    Dtsch Med Wochenschr; 1984 Jun; 109(22):886-7. PubMed ID: 6327220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Personal experience in the treatment of duodenal ulcer with ranitidine].
    Civello IM; De Giovanni L; Marcovits de Spizza F; Destito C; Barone Adesi TL; Wiel Marin A
    Clin Ter; 1983 Sep; 106(5):357-9. PubMed ID: 6315294
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M; Bargiggia S; Bianchi Porro G
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.